Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gaviscon Advance for Post-supper Acid Pocket in Obese Patients
NCT03516188Phase 3Completed
- Sponsor
- Universiti Sains Malaysia
- Start
- Jul 2016
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gaviscon advance in gastroesophageal reflux disease (GERD), sponsored by Universiti Sains Malaysia. Started Jul 2016; status: completed.
02
Drugs
gaviscon advance
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT03516188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03516188.